JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.200
+0.010 (0.46%)
Sep 18, 2026, 4:08 PM HKT

HKG:2126 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
392.09503.07757.381,0061,3831,834
Short-Term Investments
-0.165.165.535.540.7
Cash & Short-Term Investments
392.09503.22762.531,0111,3891,835
Cash Growth
-39.40%-34.01%-24.61%-27.18%-24.32%-30.26%
Accounts Receivable
----5.31-
Other Receivables
4.272.059.955.9227.3915.83
Receivables
4.272.059.955.9232.715.83
Inventory
50.946231.2634.7840.1631.4
Other Current Assets
3.993.024.9315.3423.4312.72
Total Current Assets
451.28570.3808.671,0671,4851,895
Property, Plant & Equipment
189.15210.53273.88341.13393.22365.68
Other Intangible Assets
177.78191.49582.97711.22893.68816.29
Other Long-Term Assets
14.9714.5814.8526.2719.2839.6
Total Assets
833.18986.91,6802,1462,7913,117

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
55.5262.8940.1553.6771.1672.08
Accrued Expenses
48.7766.2729.7451.0375.4988.26
Short-Term Debt
----137.3-
Current Portion of Long-Term Debt
180.69218.1361.6310555
Current Portion of Leases
8.488.2214.6316.0110.615.19
Current Unearned Revenue
16.5333.2616.8131.4211.44
Other Current Liabilities
5.075.662.117.3410.2916.93
Total Current Liabilities
315.06394.39465.05264.47310.84198.9
Long-Term Debt
471819.5157.592.595
Long-Term Leases
18.7218.2426.6540.2933.7331.85
Total Liabilities
380.78430.64511.2462.26437.06325.75

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.030.030.030.030.030.03
Additional Paid-In Capital
-6,0816,0816,0816,0816,081
Retained Earnings
-6,162-6,111-5,556-4,965-4,197-3,351
Treasury Stock
--0-0-0-0-0
Comprehensive Income & Other
6,614586.05643.91568.36470.8461.37
Shareholders' Equity
452.4556.261,1691,6842,3542,791
Total Liabilities & Equity
833.18986.91,6802,1462,7913,117

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
254.89262.56422.4318.8279.13147.04
Net Cash (Debt)
137.2240.66340.13692.651,1101,688
Net Cash Growth
-50.03%-29.24%-50.90%-37.59%-34.26%-32.69%
Net Cash Per Share
0.330.580.821.682.714.22
Filing Date Shares Outstanding
416.6405.64404.7401.56400.2396.79
Total Common Shares Outstanding
416.6405.64404.7401.56400.2396.79
Working Capital
136.23175.91343.62803.021,1741,696
Book Value Per Share
1.091.372.894.195.887.03
Tangible Book Value
274.62364.77586.2972.621,4611,975
Tangible Book Value Per Share
0.660.901.452.423.654.98
Machinery
-217.84217.95216.21189.32147.47
Construction In Progress
-0.020.070.8532.917.16
Leasehold Improvements
-232.39234.33234.76234.66208.38